Bliss GVS Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

161.15

-8.69 (-5.12%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

161.15

-8.69 (-5.12%)
16:02 Dec 20

Quality

82/100
High Financial Strength

Valuation

56/100
Affordable Valuation

Technical

65/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	577.21	747.45	751.59	770.24	800.17
Operating Expenses +	470.56	629.12	634.27	619.62	652.32
Raw Material	340.79	420.18	374.38	390.47	408.99
Increase Decrease in Cost	-11.88	-29.2	26.94	-8.35	-10.97
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	68.09	76.15	86.17	95.58	102.85
Miscellaneous Expenses	235.52	231.81	235.46	244.62	151.45
Operating Profit	106.65	118.33	117.32	150.62	147.85
Other Income	20.22	31.49	17.79	28.74	20.18
Depreciation	17.23	17.33	18.67	26.38	27.63
Interest	5.51	4.74	10.36	6.91	9.33
Profit before tax and exceptio..	104.13	127.76	106.07	146.07	131.07
Exceptional Items	0	-73.59	0	-29.2	-29.2
PBT	104.13	54.17	106.07	116.87	160.27
Provision for Taxation	30.16	31.04	29.34	35.29	29.91
Net Profit	73.97	23.13	76.73	81.58	71.96
NET Profit after MI	68.49	15.04	70.86	75.45	63.42
EPS	6.64	1.46	6.72	7.23	6.04
Operating Profit Margin (%)	18.48	15.83	15.61	19.55	18.48
Net Profit Margin (%)	11.87	2.01	9.43	9.8	7.93

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	34.80	34.90	35.00	35.00	35.10
FII	12.10	13.20	14.70	15.40	16.30
MF	0.00	0.00	0.00	0.00	0.00
Public	46.50	45.30	43.70	43.10	42.00
Others	0.00	0.00	0.00	0.00	0.00
Others	6.60	6.60	6.60	6.50	6.60